Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary and study completion dates changed from estimate of Aug 2026 to Aug 24, 2026
    • Eligibility criteria expanded, about 11 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2026 to Aug 2026
    • Site details revised
    v8
  3. Enrollment target: 18 to 12
    • Study description expanded, about 29 words
    • Site contact updated
    v7
  4. Study description expanded, about 31 words
    • Site contact updated
    v6
  5. Primary completion date: Dec 2024 to Aug 2026
    • Study completion date: Dec 2025 to Dec 2026
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2023 to Jan 6, 2023
    • Site details revised
    v3
  3. Start date: Nov 2022 to Jan 2023v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase 1 study to determine the safety of a condensed preoperative radiation regimen (10, 7, or 5 fractions) for the management of head and neck squamous cell carcinoma.
Trial Details
NCT Number NCT05538533
Lead Sponsor Medical College of Wisconsin
Conditions
(from sponsor)		 Head and Neck Cancer
Related terms Head and Neck Neoplasms
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov